Cargando…

Advances in epigenetic glioblastoma therapy

Glioblastoma multiforme (GBM) is the most lethal primary brain tumor in adults despite contemporary gold-standard first-line treatment strategies. This type of tumor recurs in virtually all patients and no commonly accepted standard treatment exists for the recurrent disease. Therefore, advances in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Dong Hoon, Ryu, Hyun-Wook, Won, Hye-Rim, Kwon, So Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392350/ https://www.ncbi.nlm.nih.gov/pubmed/28099914 http://dx.doi.org/10.18632/oncotarget.14612

Ejemplares similares

Influence of Toxicologically Relevant Metals on Human Epigenetic Regulation
por: Ryu, Hyun-Wook, et al.
Publicado: (2015)

Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc
por: Lee, Dong Hoon, et al.
Publicado: (2021)

Is Glioblastoma an Epigenetic Malignancy?
por: Maleszewska, Marta, et al.
Publicado: (2013)

Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Epigenetic pathways and glioblastoma treatment
por: Clarke, Jennifer, et al.
Publicado: (2013)

Advanced T and Natural Killer Cell Therapy for Glioblastoma
por: Yoon, Wan-Soo, et al.
Publicado: (2023)

Advances in Ophthalmic Epigenetics and Implications for Epigenetic Therapies: A Review
por: Moore, Spencer M., et al.
Publicado: (2023)

Clinical advances in epigenetic therapies for lymphoma
por: Rosenthal, Allison C., et al.
Publicado: (2023)

Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators as a Therapy for Glioblastoma
por: Nadeem Abbas, Muhammad, et al.
Publicado: (2019)

Non-Cell Autonomous and Epigenetic Mechanisms of Huntington’s Disease
por: Kim, Chaebin, et al.
Publicado: (2021)

Advances in Histone Demethylase KDM3A as a Cancer Therapeutic Target
por: Yoo, Jung, et al.
Publicado: (2020)

The Advances in Glioblastoma On-a-Chip for Therapy Approaches
por: Alves, Arielly H., et al.
Publicado: (2022)

Advances in Glioblastoma Therapy: An Update on Current Approaches
por: Angom, Ramcharan Singh, et al.
Publicado: (2023)

The good, the bad and the ugly: Epigenetic mechanisms in glioblastoma
por: Carén, Helena, et al.
Publicado: (2013)

Combination therapy to checkmate Glioblastoma: clinical challenges and advances
por: Ghosh, Debarati, et al.
Publicado: (2018)

Epigenetic Targeting of Glioblastoma
por: Romani, Massimo, et al.
Publicado: (2018)

The Key Role of DNA Methylation and Histone Acetylation in Epigenetics of Atherosclerosis
por: Lee, Han-Teo, et al.
Publicado: (2020)

The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma
por: Wu, Qiong, et al.
Publicado: (2021)

Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis
por: Markouli, Mariam, et al.
Publicado: (2022)

Epigenetic Targeting of Histone Deacetylases in Diagnostics and Treatment of Depression
por: Park, Hyun-Sun, et al.
Publicado: (2021)

Quantification and Application of Potential Epigenetic Markers in Maternal Plasma of Pregnancies with Hypertensive Disorders
por: Kim, Hyun Jin, et al.
Publicado: (2015)

Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma
por: Cruz, Nuno, et al.
Publicado: (2023)

Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification
por: Kwon, Duk-Hwa, et al.
Publicado: (2020)

Advanced Cell Therapies for Glioblastoma
por: Wang, Guangwen, et al.
Publicado: (2022)

Comparative Impact of Pharmacological Therapies on Cluster Headache Management: A Systematic Review and Network Meta-Analysis
por: Kwon, Jae-Hee, et al.
Publicado: (2022)

Adapt to Persist: Glioblastoma Microenvironment and Epigenetic Regulation on Cell Plasticity
por: Uribe, Daniel, et al.
Publicado: (2022)

A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma
por: Hasan, Hera, et al.
Publicado: (2023)

The Role of Non-Coding RNAs in Epigenetic Dysregulation in Glioblastoma Development
por: Isachesku, Ekaterina, et al.
Publicado: (2023)

Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma
por: Zhao, Binghao, et al.
Publicado: (2023)

Advances in treating glioblastoma
por: Weathers, Shiao-Pei, et al.
Publicado: (2014)

Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms
por: Torrisi, Filippo, et al.
Publicado: (2023)

Advances in Immunotherapy for Adult Glioblastoma
por: Chokshi, Chirayu R., et al.
Publicado: (2021)

Primary Glioblastoma of the Cerebellopontine Angle: Case Report and Review of the Literature
por: Lee, Ji-Hye, et al.
Publicado: (2017)

Farnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness
por: Kim, Hee Yeon, et al.
Publicado: (2018)

Editorial: Epigenetics and cellular plasticity in glioblastoma
por: Lo, Hui-Wen, et al.
Publicado: (2023)

Quantitative radiomic profiling of glioblastoma represents transcriptomic expression
por: Kong, Doo-Sik, et al.
Publicado: (2018)

The Advances in Epigenetics for Cancer Radiotherapy
por: Wang, Yuexuan, et al.
Publicado: (2022)

Tumour treating fields therapy for glioblastoma: current advances and future directions
por: Rominiyi, Ola, et al.
Publicado: (2020)

Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies
por: Kang, Hyunkoo, et al.
Publicado: (2022)

Education, Role, and Prospects of Advanced Practice Nurses in Hospice and Palliative Care in South Korea
por: Kwon, So-Hi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g01hhuvkuiajrnqnhbe8su5p9l